The association of diagnosis in the private or NHS sector on prostate cancer stage and treatment - Abstract

Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, University Forvie Site, Robinson Way, Cambridge CB2 0SR, UK.

 

To examine associations of private healthcare with stage and management of prostate cancer.

Methods: Regional population-based cancer registry information on 15 916 prostate cancer patients.

Compared with patients diagnosed in the National Health Service (NHS) (94%), those diagnosed in private hospitals (5%) were significantly more affluent (69 versus 52% in deprivation quintiles 1-2), younger (mean 69 versus 73 years) and diagnosed at earlier stage (72 versus 79% in Stages < III) (P < 0.001 for all). Private hospital of diagnosis was independently associated with lower probability of advanced disease stage [odds ratio (OR) 0.75, P = 0.002], higher probability of surgery use (OR 1.28, P = 0.037) and lower probability of radiotherapy use (OR 0.75, P = 0.001). Private hospital of diagnosis independently predicted higher surgery and lower radiotherapy use, particularly in more deprived patients aged ≤ 70.

In prostate cancer patients, private hospital diagnosis predicts earlier disease stage, higher use of surgery and lower use of radiotherapy, independently of case-mix differences between the two sectors. Substantial socioeconomic differences in stage and treatment patterns remain across centres in the NHS, even after adjusting for private sector diagnosis. Cancer registration data could be used to identify private care use on a population basis and the potential associated treatment disparities.

Written by:
Barbiere JM, Greenberg DC, Wright KA, Brown CH, Palmer C, Neal DE, Lyratzopoulos G.   Are you the author?

Reference: J Public Health (Oxf). 2011 Jul 10. Epub ahead of print.
doi: 10.1093/pubmed/fdr051

PubMed Abstract
PMID: 21745831

UroToday.com Prostate Cancer Section

 

 

email news signup